Women's Health: Female Athlete/Female Athlete Triad Clinical Trial
— Kaatsu-BFROfficial title:
Technique of Restriction of Blood Flow Associated With the Ergonomic Cycle of Upper Limbs in Women. A Randomized Pilot Study
| NCT number | NCT03618004 |
| Other study ID # | Kaatsu-BFR |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | March 1, 2018 |
| Est. completion date | August 2, 2018 |
| Verified date | November 2018 |
| Source | Real Fundación Victoria Eugenia |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Finding alternatives to improve variables such as strength and anaerobic resistance is a
subject of highly studied clinical intervention. The use of vascular occlusion associated
with physical exercise has shown efficacy in improving these aspects.
The objective is to analyze the effectiveness of upper limb training with vascular occlusion
(Kaatsu training) for the improvement of isometric strength and anaerobic capacity in women
aged 18 to 38 years.
Study design. Randomized, prospective, single-blind, follow-up clinical study. The selected
sample will be randomized into two groups: experimental and control. The intervention will
consist of ergonomic exercises with and without vascular occlusion. Isometric strength will
be assessed with a manual dynamometer, anaerobic capacity and peak power (anaerobic alactic
system) and average power (anaerobic lactic system) with the wingate test, and subjective
perception of effort with the Borg scale. The intervention will last 4 weeks, with 3 weekly
sessions of 10 minutes each. A descriptive statistical analysis will be carried out among the
dependent and independent variables of both groups. With the Kolmogórov distribution
normality test and with the Anova and t-student tests for analysis of repeated measures.
Expected results. The investigators intend to observe improvement of isometric biceps and
triceps strength and the anaerobic capacity of the group treated with vascular occlusion.
| Status | Completed |
| Enrollment | 20 |
| Est. completion date | August 2, 2018 |
| Est. primary completion date | April 12, 2018 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 18 Years to 40 Years |
| Eligibility |
Inclusion Criteria: - Women - Between 18 and 40 years old - Physically active - Without orthopedic injuries that prevented them from carrying out the exercise protocol Exclusion Criteria: - Diagnosis of chronic musculoskeletal, neurological or cardiorespiratory diseases - With diagnosis of arterial hypertension, deep vein thrombosis or diabetes - Pregnant - Not sign the informed consent document |
| Country | Name | City | State |
|---|---|---|---|
| Spain | Royal Victoria Eugenia Foundation | Madrid | Madird |
| Lead Sponsor | Collaborator |
|---|---|
| Real Fundación Victoria Eugenia |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change from baseline isometric strength of biceps after treatment and at 1 month | A Lafayette Manual Muscle Testing System force dynamometer (model 01165, USA) was used. The subject was standing with the trunk straight, the shoulders in neutral position with the arms aligned to the trunk and the elbows in 90 degrees of flexion. The evaluator requested a maximum voluntary isometric muscle contraction in elbow flexion, maintaining it for 5 seconds. Three repetitions were performed, with 5 minutes of rest between each series, the reference value being the average of the value obtained between the 3 repetitions. | Screening visit, within the first seven days after treatment and after one month follow-up visit] | |
| Secondary | Change from baseline isometric strength of triceps after treatment and at 1 month | A Lafayette Manual Muscle Testing System force dynamometer (model 01165, USA) was used. The subject was standing with the trunk straight, the shoulders in neutral position with the arms aligned to the trunk and the elbows in 90 degrees of flexion. The evaluator requested a maximum voluntary isometric muscle contraction in elbow extension, maintaining it for 5 seconds. Three repetitions were performed, with 5 minutes of rest between each series, the reference value being the average of the value obtained between the 3 repetitions. | Screening visit, within the first seven days after treatment and after one month follow-up visit | |
| Secondary | Change from baseline peak power after treatment and at 1 month | The WinGate test was used. The equipment used was an ergonomic clico for upper limbs (Excite® top seat, technogyn, Brazil). Each subject was placed seated, so that the center of the glenohumeral joint was aligned with the axis of the cranks of the equipment, with 90 degrees of knee flexion, which were aligned with shoulders and feet. The horizontal distance was adjusted so that the elbows were not in maximum extension and allowing the comfort of the participants. | Screening visit, within the first seven days after treatment and after one month follow-up visit | |
| Secondary | Change from baseline relative power peak after treatment and at 1 month | The WinGate test was used. The equipment used was an ergonomic clico for upper limbs (Excite® top seat, technogyn, Brazil). Each subject was placed seated, so that the center of the glenohumeral joint was aligned with the axis of the cranks of the equipment, with 90 degrees of knee flexion, which were aligned with shoulders and feet. The horizontal distance was adjusted so that the elbows were not in maximum extension and allowing the comfort of the participants. | Screening visit, within the first seven days after treatment and after one month follow-up visit | |
| Secondary | Change from baseline medium power after treatment and at 1 month | The WinGate test was used. The equipment used was an ergonomic clico for upper limbs (Excite® top seat, technogyn, Brazil). Each subject was placed seated, so that the center of the glenohumeral joint was aligned with the axis of the cranks of the equipment, with 90 degrees of knee flexion, which were aligned with shoulders and feet. The horizontal distance was adjusted so that the elbows were not in maximum extension and allowing the comfort of the participants. | Screening visit, within the first seven days after treatment and after one month follow-up visit | |
| Secondary | Change from baseline relative medium power after treatment and at 1 month | The WinGate test was used. The equipment used was an ergonomic clico for upper limbs (Excite® top seat, technogyn, Brazil). Each subject was placed seated, so that the center of the glenohumeral joint was aligned with the axis of the cranks of the equipment, with 90 degrees of knee flexion, which were aligned with shoulders and feet. The horizontal distance was adjusted so that the elbows were not in maximum extension and allowing the comfort of the participants. | Screening visit, within the first seven days after treatment and after one month follow-up visit | |
| Secondary | Change from baseline fatigue index after treatment and at 1 month | The WinGate test was used. The equipment used was an ergonomic clico for upper limbs (Excite® top seat, technogyn, Brazil). Each subject was placed seated, so that the center of the glenohumeral joint was aligned with the axis of the cranks of the equipment, with 90 degrees of knee flexion, which were aligned with shoulders and feet. The horizontal distance was adjusted so that the elbows were not in maximum extension and allowing the comfort of the participants. | Screening visit, within the first seven days after treatment and after one month follow-up visit | |
| Secondary | Change from baseline subjective perception of effort after treatment and at 1 month | The subjective perception of effort was evaluated with the Borg CR-10 scale. One minute after the end of the evaluation, the effort perceived by the subjects was quantified from 0 to 10, with 0 the minimum perceived effort and 10 the maximum. | Screening visit, within the first seven days after treatment and after one month follow-up visit | |
| Secondary | Change from baseline heart rate after treatment and at 1 month | The heart rate was assessed through a cardiac frequency meter (model Onrhythm 310, Geonaute, France). The resting heart rates were evaluated and one minute after the intervention. | Screening visit, within the first seven days after treatment and after one month follow-up visit |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03210558 -
Study of Testosterone and Athlete Response
|
Phase 2 |